JSE may benefit from positive economic and vaccine news on Thursday 🔒
The JSE may benefit from some optimism on global markets on Thursday, with focus on positive data and a possible Covid-19 vaccine.
Data earlier showed industrial deflation in China slowed in June, while consumer inflation was higher than expected.A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
JSE faces mixed Asian markets on WednesdayUS stocks were lower overnight, as the hope of an economic rebound competes with surging Covid-19 cases
Read more »
JSE firmer on promise of more US Covid-19 stimulus measuresWhile the surge in infections is weighing on global markets, all the JSE major indices are firmer with gold gaining 0.25%
Read more »
MARKET WRAP: JSE firms for a second day despite virus worriesBoth the all share and top 40 gained on the day, but the rand weakened
Read more »
JSE muted as focus remains on surge in Covid-19 casesDespite the spike in infections, some analysts say market participants remain optimistic that the worst is over
Read more »
CHRIS GILMOUR: These are trends developing for life in post-Covid-19 timesUntil a vaccine is developed, many consumers will be wary of returning to shopping malls and so will discover the benefits of online shopping
Read more »
New Covid-19 strain up to nine times more infectious, scientists warnResearchers are concerned that the newer, dominant strain will affect the potency of vaccines being tested
Read more »